Results 21 to 30 of about 8,503,937 (347)

Cardiovascular risk [PDF]

British Journal of Clinical Pharmacology, 2012
Cardiovascular disease is a major, growing, worldwide problem. It is important that individuals at risk of developing cardiovascular disease can be effectively identified and appropriately stratified according to risk. This review examines what we understand by the term risk, traditional and novel risk factors, clinical scoring systems, and the use of ...
openaire   +4 more sources

Abacavir and cardiovascular risk [PDF]

Current Opinion in Infectious Diseases, 2010
This review focuses on current studies addressing the association of abacavir (ABC) therapy and myocardial risk in HIV-infected patients, discusses potential pathogenetic mechanisms, and suggests a preliminary algorithm for decision making regarding ABC therapy in daily clinical practise.The D:A:D study was the first to reveal an increased rate of ...
Behrens, G.M.N., Reiss, P.
openaire   +4 more sources

Circulating linoleic acid at the time of myocardial infarction and risk of primary ventricular fibrillation

Scientific Reports, 2022
Primary ventricular fibrillation (PVF) is a major driver of cardiac arrest in the acute phase of ST-segment elevation myocardial infarction (STEMI). Enrichment of cardiomyocyte plasma membranes with dietary polyunsaturated fatty acids (PUFA) reduces ...
Teresa Oliveras, Iolanda Lázaro, Ferran Rueda, Germán Cediel, Deepak L. Bhatt, Montserrat Fitó, Francisco Madrid-Gambin, Oscar J. Pozo, William S. Harris, Cosme García-García, Aleix Sala-Vila, Antoni Bayés-Genís   +11 more
doaj   +1 more source

Cardiovascular Risk Factors and Physical Activity for the Prevention of Cardiovascular Diseases in the Elderly

International Journal of Environmental Research and Public Health, 2021
Cardiovascular diseases create an important burden on the public health systems, especially in the elderly, mostly because this group of patients frequently suffer from multiple comorbidities.
L. Ciumărnean, M. Milaciu, V. Negrean, O. Orășan, Ș. Vesa, Octavia Sălăgean, S. Iluț, S. Vlaicu   +7 more
semanticscholar   +1 more source

Triglycerides and Cardiovascular Risk [PDF]

Current Cardiology Reviews, 2009
In 1996 a meta-analysis was published showing that an increase in plasma triglyceride (TG) levels was associated with an increase in CHD risk, even after adjustment for high density lipoprotein cholesterol (HDL-C) levels. Very recently, two studies were published that further extent the early observation and showed the importance of nonfasting plasma ...
E. S. Stroes, J. J.P. Kastelein, M. E. Visser, G. M. Dallinga-Thie, K. E.L. Harchaoui   +4 more
openaire   +3 more sources

Sex X Time Interactions in Lp(a) and LDL-C Response to Evolocumab

Biomedicines, 2023
The aim of this study was to evaluate whether there were significant sex x time interactions in lipoprotein(a) (Lp(a)) and low-density lipoprotein cholesterol (LDL-C) response to treatment with the Proprotein Convertase Subtilisin/Kexin type 9 inhibitor (
Federica Fogacci, Serra İlayda Yerlitaş, Marina Giovannini, Gökmen Zararsız, Paolo Lido, Claudio Borghi, Arrigo F. G. Cicero   +6 more
doaj   +1 more source

2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

Circulation, 2014
Preamble and Transition to ACC/AHA Guidelines to Reduce Cardiovascular Risk S50 The goals of the American College of Cardiology (ACC) and the American Heart Association (AHA) are to prevent cardiovascular diseases (CVD); improve the management of people
D. Goff, D. Lloyd‐Jones, G. Bennett, S. Coady, R. D'Agostino, R. Gibbons, P. Greenland, D. Lackland, D. Levy, C. O’Donnell, Jennifer G. Robinson, J. Schwartz, Susan T. Shero, Sidney C. Smith, P. Sorlie, N. Stone, Peter W. F. Wilson, Harmon S. Jordan, Lev Nevo, Janusz Wnek, Jeffrey L. Anderson, L. Halperin, Nancy M. Albert, Biykem Bozkurt, R. Brindis, Lesley H. Curtis, D. Demets, J. Hochman, Richard J. Kovacs, E. M. Ohman, S. Pressler, Frank W. Sellke, Win-Kuang Shen   +32 more
semanticscholar   +1 more source

Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk: The STRENGTH Randomized Clinical Trial.

Journal of the American Medical Association (JAMA), 2020
Importance It remains uncertain whether the omega-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) reduce cardiovascular risk. Objective To determine the effects on cardiovascular outcomes of a carboxylic acid formulation of EPA
Stephen J. Nicholls, A. Lincoff, Michelle Garcia, Dianna Bash, C. Ballantyne, P. Barter, M. Davidson, J. Kastelein, W. Koenig, D. McGuire, D. Mozaffarian, P. Ridker, K. Ray, B. Katona, A. Himmelmann, Larrye E. Loss, M. Rensfeldt, Torbjörn Lundström, R. Agrawal, V. Menon, K. Wolski, S. Nissen   +21 more
semanticscholar   +1 more source

Hyperuricemia and Cardiovascular Risk

Cureus, 2021
As the prevalence of hyperuricemia (elevated uric acid levels in the blood) increases, the relationship between serum uric acid levels and cardiovascular risk has garnered increased interest. Several studies have highlighted that elevated uric acid levels are likely tied to increased cardiovascular disease risk.
Milad K Heydari, Komal M Patel, Marc M Kesselman, Lauren Shahin   +3 more
openaire   +3 more sources

Non-HDL cholesterol predicts coronary heart disease in primary prevention: findings from an Italian a 40-69 year-old cohort in general practice

Monaldi Archives for Chest Disease, 2004
Scopo. La frazione lipoproteica denominata “colesterolo non-HDL” viene raccomandata come un indice di rischio coronarico (RC) associata alla dislipidemia combinata ed è stata trovata un utile fattore predittivo del rischio coronarico nei pazienti ...
Anna V. Ciardullo, Luigi Azzolini, Massimo Bevini, Tiziano Cadioli, Paolo Malavasi, Alberto Morellini, Monica M. Daghio, Patrizia Guidetti, Manuela Lorenzetti, Carlo Carapezzi   +9 more
doaj   +1 more source